Related Experiment Video
Updated: May 10, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Fulminant hepatic failure and hepatomegaly caused by diffuse liver metastases from small cell lung carcinoma: 2
Kazuhide Sato1, Yoshihiro Takeyama, Taku Tanaka
1The Department of Respiratory Medicine, Toyohashi Municipal Hospital, Japan. kazuhydesato@yahoo.co.jp
Abstract:
Fulminant hepatic failure (FHF) is defined as a liver disease that causes encephalopathy within 8 weeks of onset in the absence of pre-existing liver disease. Although liver metastases are commonly found in cancer patients, FHF secondary to diffuse liver infiltration is rare. Here, we report the rare autopsy cases of patients with small cell lung carcinoma (SCLC) and secondary FHF. These patients presented with remarkable hepatomegaly and a near complete replacement of the liver parenchyma with metastatic tumor. Neoplastic involvement of the liver should be considered in the differential diagnosis of FHF.
Related Concept Videos
Hepatic Encephalopathy
Cirrhosis II: Pathophysiology

